My Time as Deputy Director for Intramural Research: The Recent Years
BY MICHAEL GOTTESMAN, DDIR
In recent years, there has been a gradual evolution of the intramural research program to reflect our need to enhance team science, shared resources, and collaborations; build a community of increased diversity, equity, inclusion, and accessibility (DEIA); and strengthen our clinical program including changes in the oversight of the NIH Clinical Center and human subjects research, and paying more attention to the career development of our clinical researchers.
Former NIH Director Francis Collins Named Temporary Science Advisor to the President
Former NIH Director Francis Collins, who retired from that position in December 2021, was recently named temporary science advisor to President Joe Biden and co-chair of the President’s Council of Advisors on Science and Technology.
New Web Application to Study Cellular Responses to Glucocorticoids
NIH researchers created a new web tool, called GCgx, that will allow scientists to study how different human cell types will respond to glucocorticoids, a powerful class of steroid drugs used for anti-inflammatory and immunosuppressive therapy and to fight an overactive immune system.
Are you an NIH postdoc or clinical fellow? Do you have an idea, or an issue, or just want to meet fellows outside of your own institute or lab? The NIH Fellows Committee (FelCom) is here to represent you.
Read about NIH scientific advances and discoveries by intramural scientists: first stem-cell model of eye disease; drugs targeting skeletal muscle metabolism may help treat diabetes; personalized immunotherapy a potential treatment for metastatic breast cancer; suicides by drug overdose increase in some groups despite overall decline; new species of microbes discovered on human skin; and the brain influences insulin production.